Lek Shareholders Give their Approval for the Proposed Resolutions
Ljubljana, 12 November 2002 – Lek Pharmaceuticals d.d. announces that at the 17th General Meeting held today its shareholders adopted the proposed resolutions that had been rejected at the 16th General Meeting of 27 September 2002. As a result, and following the agreement reached between Novartis and a group of major Lek shareholders on the increased price offered for Lek shares, the takeover will be successfuly completed.
At the headquarters of the company Lek, 17th General Meeting of the joint-stock company Lek was held today upon the request made by the minority of shareholders. The following two resolutions were discussed and adopted:
- Resolution on the modification to Article 67 of the Statute of the Joint-Stock Company Lek, which will enable Novartis’ shares to obtain voting rights after the expiration of the public offer and after the issuance of a declaratory decision by the Securities Market Agency.
- Resolution on the amended power granted to the Board of Management of Lek for the purchase of own shares, which will enable own shares of the company Lek to equally participate in the Novartis’ offer.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
- * *
For additional information, please contact: Miša Komar Žiberna, Lek’s Corporate Communications Telephone: + 386 1 580 22 43